Your First Week on Semaglutide: What to Expect

Before your first weekly injection, check your prescription label, concentration, syringe marking and storage instructions. Choose a time when you can focus, not a rushed moment before leaving home. Set up clean supplies and a sharps container, and make sure you know the technique before opening a needle. Our first-injection guide walks through vial preparation.

Afterward, record the dose and time and return the medication to its labeled storage conditions. You do not need a special “last meal,” a fasting period or an unusually intense workout. For FDA-approved Wegovy injections, dosing may be with or without food; follow your own label. A normal, modest meal can be easier to evaluate than an unusually large celebration dinner.

Some people notice appetite changes within days, while others need more time and dose titration. There is no evidence-based promise that day two will be the worst day or that hunger must disappear by day seven. Avoid making plans around a fixed symptom calendar. Keep your routine flexible enough to accommodate rest or smaller meals if needed.

A return of hunger near the end of a week is information to record, not an instruction to inject early. Likewise, nausea does not establish that the dose is “working better.” Tell your Join Luma clinician if effects are difficult to manage or if you are unsure about the next dose.

The Wegovy prescribing information and Medication Guide describes an elimination half-life of approximately one week. Half-life is the time it takes the body to eliminate about half the circulating medication, not the time at which all effects switch off. Medication remains after the first week, and repeated weekly injections build exposure over time.

This explains why one dose is not a full picture of longer-term response, and why taking extra medication can create prolonged problems rather than a quick correction. It does not mean your appetite must stay exactly the same every day. Pharmacokinetics describe drug exposure; meals, sleep, activity and individual response also affect how you feel.

Wegovy’s injection initiation schedule increases gradually to reduce gastrointestinal adverse reactions. The first dose is intentionally an introduction, not the eventual maintenance exposure used in the major weight-management trial. Your Join Luma clinician selects your compounded prescription and follow-up plan; do not transfer a brand schedule directly to syringe units.

If you are new to treatment, give the prescribed plan time. If you are switching from another medication or returning after a break, tell the clinician your exact product, dose and last administration date. A previous GLP-1 prescription does not make every starting dose appropriate. See how long semaglutide takes to work for a broader timeline.

Try smaller meals, eat slowly and stop at comfortable satisfaction. Keep familiar protein foods and easy-to-digest options available instead of waiting until you are very hungry and ordering an oversized meal. Sip fluids consistently, following any medical fluid restrictions. A bottle nearby can be a useful reminder, but there is no single water target suitable for every patient.

Constipation can become noticeable as your intake changes. The Treatment for Constipation recommends gradual fiber changes, adequate fluid and activity. Avoid making multiple abrupt diet changes at once: a large fiber increase, very restrictive eating and a new supplement make it harder to identify what is causing discomfort.

Keep a simple record of symptoms and possible meal triggers. If you cannot keep fluids down, have very little urine or feel markedly dizzy, seek urgent care. Do not interpret dehydration as expected weight loss, and do not wait for a routine check-in to report ongoing poor intake.

Join Luma’s oral ODT option consists of once-daily compounded dissolving tablets, built in with ondansetron for anti-nausea support. That is different from the once-weekly injection format discussed in this guide. Use your ODT prescription directions, not an injection schedule, and do not combine the two formats unless your clinician directs it.

Ondansetron support does not guarantee that nausea will not happen or make persistent vomiting safe to manage without assessment. Tell the clinician about all medicines and constipation symptoms, because anti-nausea treatment also needs individualized review. Results and pharmacokinetic details from Wegovy injection studies should not be presented as outcomes demonstrated for compounded ODT tablets.

If you are comparing formats, our injection overview explains the weekly option. Ask Join Luma which formulation fits your medical history and routine rather than switching solely because of a difficult first meal or an anecdote about faster results.

Seek urgent care for severe or persistent abdominal pain, especially pain that spreads to your back, persistent vomiting, inability to keep fluids down, or signs of dehydration such as very little urine or marked dizziness. These are not symptoms to simply push through until your next appointment. Severe stomach pain can signal pancreatitis or another condition needing prompt assessment.

Call 911 for trouble breathing, swelling of the face, lips, tongue or throat, fainting, or other signs of a severe allergic reaction. Do not take another dose while a serious medication reaction is being assessed. If you use insulin or a sulfonylurea, ask your clinician about low blood sugar and follow your existing treatment plan for it. The Wegovy prescribing information and Medication Guide and Zepbound prescribing information and Instructions for Use describe these precautions.

Your prescription label and Join Luma clinician’s directions take priority over general information about brand-name products. Compounded semaglutide and compounded tirzepatide are not FDA-approved. FDA-approved brand labels provide useful reference information, but their devices, concentrations, storage allowances and study results do not automatically apply to a compounded prescription.

The Understanding the Risks of Compounded Drugs explains this distinction. Keep the pharmacy label available when asking a question: it identifies the medication, concentration, directions and beyond-use date. A photograph of that label and the supplied syringe can help the care team resolve a measurement question without guessing. Never use someone else’s dose or syringe marking as your own instructions.